Treatment with L-arabinose has proven to cause a reduction of insulin concentrations and elevated insulin sensitivity in metabolic syndrome rats; thus, these changes could be partially responsible for the lowering effect on blood pressure. The gene discussed is INS; the disease is metabolic syndrome.